I for one would not want to see ZCC listed without a bonifide success and a new CEO/Chairman, nice to dream.

Personally I would much prefer to see both companies sold. If the numbers Don bandies about are in the zone of reality, with a base case for both companies cumulatively exceeding $100B in potential revenues, it is hard to understand why a deal could not be struck to sell both companies together for $2-3B in cash or cash and shares of the aquiring co. The fact that Eversana and Cencora are both involved in this would suggest the numbers are at least reasonable. The fact that no significant business gets accomplished year after year after year suggests the opposite.  

Would love to get paid out sooner than later and see the science in business hands that can actually accomplish something with it.